Diagnostic Partnering Opportunities

Axela provides platforms that are uniquely positioned to address the emergence of biomarker panels in routine clinical diagnostics. The company is currently seeking opportunities for platform licensing in specific markets, or disease areas. Content can be transferred to the existing platforms or incorporated in instrument formats specifically suited to the partners needs.

Axela also offers partners an attractive business model to advance novel diagnostic biomarkers together. Early stage content can be made available in an RUO offering in order to build clinical data and acceptance on a cost effective basis. Axela is currently expanding its library of proprietary biomarker content for multiplexed research or diagnostic assays. Of particular interest are biomarkers that would find the greatest long term utility in point of use settings.

Commercial partners are encouraged to contact us for further discussion. Please inquire by emailing Email